215 related articles for article (PubMed ID: 24602011)
1. Diagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancer.
Miyake M; Nakai Y; Anai S; Tatsumi Y; Kuwada M; Onishi S; Chihara Y; Tanaka N; Hirao Y; Fujimoto K
Cancer Sci; 2014 May; 105(5):616-22. PubMed ID: 24602011
[TBL] [Abstract][Full Text] [Related]
2. Spectrophotometric photodynamic detection involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in voided urine.
Nakai Y; Ozawa T; Mizuno F; Onishi S; Owari T; Hori S; Morizawa Y; Tatsumi Y; Miyake M; Tanaka N; Tsuruta D; Fujimoto K
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2309-2316. PubMed ID: 28726046
[TBL] [Abstract][Full Text] [Related]
3. High diagnostic efficacy of 5-aminolevulinic acid-induced fluorescent urine cytology for urothelial carcinoma.
Yamamichi G; Nakata W; Tani M; Tsujimura G; Tsujimoto Y; Nin M; Mimura A; Miwa H; Tsujihata M
Int J Clin Oncol; 2019 Sep; 24(9):1075-1080. PubMed ID: 30976938
[TBL] [Abstract][Full Text] [Related]
4. [Fluorescence cytology of the urinary bladder].
Tauber S; Liedl B; Schneede P; Liessmann F; Waidelich R; Hofstetter A
Urologe A; 2001 May; 40(3):217-21. PubMed ID: 11405131
[TBL] [Abstract][Full Text] [Related]
5. Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples.
Cunderlíková B; Wahlqvist R; Berner A; Vasovic V; Warloe T; Nesland JM; Peng Q
Cytopathology; 2007 Apr; 18(2):87-95. PubMed ID: 17397493
[TBL] [Abstract][Full Text] [Related]
6. [Fluorescence cytology. Improvement of urinary cytology].
Tritschler S; Tauber S; Meier R; Stepp H; Karl A; Zaak D; Stief CG
Urologe A; 2007 Sep; 46(9):1121-3. PubMed ID: 17634912
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the sensitivity and specificity of urine cytology, urinary nuclear matrix protein-22 and multitarget fluorescence in situ hybridization assay in the detection of bladder cancer.
Kehinde EO; Al-Mulla F; Kapila K; Anim JT
Scand J Urol Nephrol; 2011 Mar; 45(2):113-21. PubMed ID: 21091091
[TBL] [Abstract][Full Text] [Related]
8. New aspect of photodynamic diagnosis of bladder tumors: fluorescence cytology.
Pytel A; Schmeller N
Urology; 2002 Feb; 59(2):216-9. PubMed ID: 11834388
[TBL] [Abstract][Full Text] [Related]
9. A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study.
Davis N; Shtabsky A; Lew S; Rona R; Leibovitch I; Nativ O; Cohen M; Mor Y; Lindner U; Glickman Y; Matzkin H; Tsivian A; Gofrit O; Yossepovitch O
Eur Urol Focus; 2018 Apr; 4(3):388-394. PubMed ID: 28753799
[TBL] [Abstract][Full Text] [Related]
10. Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A multicenter phase III study.
Nakai Y; Inoue K; Tsuzuki T; Shimamoto T; Shuin T; Nagao K; Matsuyama H; Oyama M; Furuse H; Ozono S; Miyake M; Fujimoto K
Int J Urol; 2018 Aug; 25(8):723-729. PubMed ID: 29999205
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid: a new procedure with high sensitivity for detection of hardly visible urothelial neoplasias.
Kriegmair M; Stepp H; Steinbach P; Lumper W; Ehsan A; Stepp HG; Rick K; Knüchel R; Baumgartner R; Hofstetter A
Urol Int; 1995; 55(4):190-6. PubMed ID: 8588264
[TBL] [Abstract][Full Text] [Related]
12. The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA).
Inoue K; Matsuyama H; Fujimoto K; Hirao Y; Watanabe H; Ozono S; Oyama M; Ueno M; Sugimura Y; Shiina H; Mimata H; Azuma H; Nagase Y; Matsubara A; Ito YM; Shuin T
Photodiagnosis Photodyn Ther; 2016 Mar; 13():91-96. PubMed ID: 26751700
[TBL] [Abstract][Full Text] [Related]
13. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review.
Önal B; Han Ü; Yilmaz S; Köybasioglu F; Altuğ U
Diagn Cytopathol; 2015 Apr; 43(4):307-14. PubMed ID: 25488052
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Advances in Urine Cytology.
Xing J; Reynolds JP
Surg Pathol Clin; 2018 Sep; 11(3):601-610. PubMed ID: 30190143
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the nuclear matrix protein 22 with voided urine cytology and BTA stat test in the diagnosis of transitional cell carcinoma of the bladder.
Sözen S; Biri H; Sinik Z; Küpeli B; Alkibay T; Bozkirli I
Eur Urol; 1999 Sep; 36(3):225-9. PubMed ID: 10450007
[TBL] [Abstract][Full Text] [Related]
16. Protoporphyrin IX induced by 5-aminolevulinic acid in bladder cancer cells in voided urine can be extracorporeally quantified using a spectrophotometer.
Nakai Y; Anai S; Onishi S; Masaomi K; Tatsumi Y; Miyake M; Chihara Y; Tanaka N; Hirao Y; Fujimoto K
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):282-8. PubMed ID: 25595357
[TBL] [Abstract][Full Text] [Related]
17. BTA quantitative assay and NMP22 testing compared with urine cytology in the detection of transitional cell carcinoma of the bladder.
Casetta G; Gontero P; Zitella A; Pelucelli G; Formiconi A; Priolo G; Martinasso G; Mengozzi G; Aimo G; Viberti L; Tizzani A
Urol Int; 2000; 65(2):100-5. PubMed ID: 11025432
[TBL] [Abstract][Full Text] [Related]
18. The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?
Pierconti F; Martini M; Fiorentino V; Cenci T; Capodimonti S; Straccia P; Sacco E; Pugliese D; Cindolo L; Larocca LM; Bassi PF
Urol Oncol; 2021 Feb; 39(2):131.e17-131.e21. PubMed ID: 32773233
[TBL] [Abstract][Full Text] [Related]
19. Hexylaminolevulinate-mediated fluorescent urine cytology with a novel automated detection technology for screening and surveillance of bladder cancer.
Miyake M; Nakai Y; Nishimura N; Ohnishi S; Oda Y; Fujii T; Owari T; Hori S; Morizawa Y; Gotoh D; Anai S; Torimoto K; Tanaka N; Hirao Y; Fujimoto K
BJU Int; 2021 Aug; 128(2):244-253. PubMed ID: 33580627
[TBL] [Abstract][Full Text] [Related]
20. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
